Synthetic glycoconjugates based on Leishmania lipophosphoglycan structures as potential anti-leishmaniasis vaccines
Leishmania are a genus of sandfly-transmitted protozoan parasites that cause a spectrum of debilitating and often fatal diseases in humans throughout the tropics and subtropics. The disease (termed leishmaniasis) torments over 12 million people worldwide, making 2.4 million people disabled and causi...